My Companies
Notification
Account
Log Out
Back

Natco Pharma Receives Seven USFDA Observations After Kothur Plant Inspection


21 November 2026
Natco Pharma Ltd.

Natco Pharma said the USFDA inspected its Kothur, Hyderabad manufacturing facility from November 12 to 20, 2026 and issued seven Form-483 observations, which the company described as procedural and said it would address comprehensively within stipulated timelines.


Recent Events

Company Information